Laurent M.
- Country
- France
- Department
- Dermatology
Research Overview
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630).
Data & Insights
Has run more than one trial at 276 of 495 partner sites.
Specializations
Melanoma Research
Specializes in advanced treatments for metastatic and unresectable melanoma, with particular emphasis on novel immunotherapy combinations and targeted therapies. Investigates treatments for both early-stage and advanced disease states.
- Adjuvant therapy for high-risk melanoma
- BRAF-mutated melanoma treatment
- Immunotherapy resistance management
Focuses on developing treatment strategies for various stages of melanoma, from resectable to metastatic disease.
Skin Cancer Therapeutics
Conducts research in cutaneous squamous cell carcinoma and other skin malignancies, exploring innovative treatment approaches and combination therapies.
- Advanced squamous cell carcinoma
- Actinic keratosis management
- Novel therapeutic combinations
Evaluates both systemic and targeted treatments for various skin cancers, including rare variants.
Immunotherapy Applications
Leads investigations into immune checkpoint inhibitor therapies and their combinations, particularly focusing on PD-1/PD-L1 pathway targeting.
- Combination immunotherapy approaches
- Novel immune-based treatments
- Biomarker-driven therapy selection
Explores innovative immunotherapy combinations and sequential treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.